We are live on ! Find out more
SS

Steve Schonfeld Schonfeld Strategic Advisors

AUM $27.9B
1-Year Est. Return 51.18%
 

Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.

This Fund
S&P 500
This Quarter Est. Return
-0.8%
1 Year Est. Return
+51.18%
3 Year Est. Return
+146.2%
5 Year Est. Return
+181.83%
10 Year Est. Return
+1,776.88%
AUM
$11.9B
AUM Growth
+$1.64B
Cap. Flow
+$3.17B
Cap. Flow %
26.56%
Top 10 Hldgs %
6.6%
Holding
3,409
New
939
Increased
912
Reduced
776
Closed
491

Top Buys

Rank Stock Value
1
FIS icon
Fidelity National Information Services
FIS
+$94M
2
EXPE icon
Expedia Group
EXPE
+$81.1M
3
AIG icon
American International
AIG
+$68.7M
4
AMZN icon
Amazon
AMZN
+$68M
5
CRBG icon
Corebridge Financial
CRBG
+$65.9M

Top Sells

Rank Stock Value
1
GEN icon
Gen Digital
GEN
+$94.3M
2
FERG icon
Ferguson
FERG
+$70.5M
3
BIO icon
Bio-Rad Laboratories Class A
BIO
+$66.2M
4
HIG icon
Hartford Financial Services
HIG
+$65.2M
5
MTB icon
M&T Bank
MTB
+$60.7M

Sector Composition

Rank Sector Weight
1 Financials 22.69%
2 Technology 16.29%
3 Consumer Discretionary 11.16%
4 Industrials 10.34%
5 Healthcare 8.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SOUN icon
2601
SoundHound AI
SOUN
$3.11B
$71K ﹤0.01%
21,600
+6,800
+46% +$22.8K
CAMP
2602
DELISTED
CalAmp Corp.
CAMP
$71K ﹤0.01%
+800
New +$91K
BBIG
2603
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
$71K ﹤0.01%
+3,830
New +$76.2K
RIDE
2604
DELISTED
Lordstown Motors Corp. Class A Common Stock
RIDE
$71K ﹤0.01%
+2,587
New +$82.4K
IMTXW
2605
DELISTED
Immatics N.V. Warrants
IMTXW
$68K ﹤0.01%
25,250
– –
STSA
2606
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$68K ﹤0.01%
11,300
-100
-0.9% -$567
RDW icon
2607
Redwire
RDW
$2.84B
$67K ﹤0.01%
27,700
-13,700
-33% -$42.3K
AMRX icon
2608
Amneal Pharmaceuticals
AMRX
$6.19B
$65K ﹤0.01%
+32,352
New +$90.7K
TV icon
2609
Televisa
TV
$1.48B
$64K ﹤0.01%
+12,000
New +$84.2K
TCRR
2610
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$64K ﹤0.01%
35,400
-29,000
-45% -$84.1K
OPTU
2611
Optimum Communications Inc
OPTU
$328M
$63K ﹤0.01%
+10,777
New +$103K
RLGT icon
2612
Radiant Logistics
RLGT
$395M
$62K ﹤0.01%
+10,800
New +$76K
SPRY icon
2613
ARS Pharmaceuticals
SPRY
$532M
$62K ﹤0.01%
11,600
-8,800
-43% -$43.4K
ABUS icon
2614
Arbutus Biopharma
ABUS
$1.03B
$61K ﹤0.01%
+31,900
New +$75.1K
CNVS icon
2615
Cineverse
CNVS
$60.4M
$61K ﹤0.01%
7,760
-35
-0.4% -$388
BNED icon
2616
Barnes & Noble Education
BNED
$430M
$60K ﹤0.01%
249
-45
-15% -$12K
CVM icon
2617
CEL-SCI Corp
CVM
$24.3M
$60K ﹤0.01%
647
-836
-56% -$101K
PMCB icon
2618
PharmaCyte Biotech
PMCB
$5.64M
$60K ﹤0.01%
24,800
-1,400
-5% -$3.54K
SVM
2619
Silvercorp Metals
SVM
$2.8B
$60K ﹤0.01%
25,900
+15,300
+144% +$36.8K
GPGI
2620
GPGI Inc
GPGI
$3.79B
$59K ﹤0.01%
14,087
+1,839
+15% +$8.62K
RTX icon
2621
CALL
RTX Corp
RTX
$282B
$59K ﹤0.01%
+50,000
New +$4.53M
MPU icon
2622
Mega Matrix
MPU
$14.7M
$58K ﹤0.01%
34,100
+200
+0.6% +$251
TNGX icon
2623
Tango Therapeutics
TNGX
$4.13B
$58K ﹤0.01%
+16,000
New +$68.3K
ADVM
2624
DELISTED
Adverum Biotechnologies
ADVM
$57K ﹤0.01%
6,000
– –
RJET
2625
Republic Airways Holdings
RJET
$879M
$57K ﹤0.01%
2,320
-520
-18% -$17.8K
103 104
105
106 107

Similar funds

UIM
USS Investment Management London, United Kingdom $27.8B AUM 39.42% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
CM
Capula Management Grand Cayman, Cayman Islands $28B AUM 22.67% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $27.6B AUM 31.92% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return
Los Angeles Capital Management
Los Angeles Capital Management Los Angeles, California $27.2B AUM 43.16% 1-Year Est. Return

Steve Schonfeld's Q3 2022 Portfolio in Review

As of Q3 2022, Steve Schonfeld held 3,409 positions worth $11.9B, up 16% from $10.3B the previous quarter. Its ten largest holdings account for 6.6% of the portfolio.

Steve Schonfeld deployed $3.17B of net new capital in Q3 2022, opening 939 new positions and adding to 912 existing holdings. Its largest new stake was Corebridge Financial: 3,204,461 shares worth $63.1M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Gen Digital, an estimated $94.3M trimmed.

  • Steve Schonfeld's largest Q3 2022 buy was Corebridge Financial: 3,204,461 shares worth $63.1M.
  • Steve Schonfeld added most to Fidelity National Information Services in Q3 2022, an estimated $94M increase.
  • Steve Schonfeld's biggest Q3 2022 reduction was Gen Digital, cutting an estimated $94.3M.
  • Steve Schonfeld fully exited UMB Financial in Q3 2022, selling an estimated $33.6M.
  • Steve Schonfeld's ten largest holdings make up 6.6% of its $11.9B portfolio in Q3 2022.
  • Steve Schonfeld opened 939 new positions and closed 491 in Q3 2022.
  • Steve Schonfeld's portfolio value rose 16% quarter-over-quarter to $11.9B.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.